Albuminuria and Mortality in Hypertension
Authors: Kristian Wachtell, Michael Hecht Olsen, Hans Ibsen
Journal: Annals of Internal Medicine (2004)

Letters3 August 2004Albuminuria and Mortality in HypertensionKristian Wachtell, MD, PhD, Michael Hecht Olsen, MD, PhD, and Hans Ibsen, MDKristian Wachtell, MD, PhDFrom Copenhagen, Denmark.Search for more papers by this author, Michael Hecht Olsen, MD, PhDFrom Copenhagen, Denmark.Search for more papers by this author, and Hans Ibsen, MDFrom Copenhagen, Denmark.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-141-3-200408030-00025 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:When hazard ratios are adjusted for risk factors as in Tables 1 and 2 in our paper, blood pressure does not enter the Cox proportional hazards model. In our study sample, the relative impact of blood pressure on the relation between albuminuria and cardiovascular outcome was minor compared with the other risk factors that were included in the model. One reason may be that the LIFE study recruited patients with a relatively narrow blood pressure range (that is, systolic blood pressure between 160 and 200 mm Hg or diastolic blood pressure between 95 and 115 mm Hg) and ...References1. Wachtell K, Olsen MH, Dahlöf B, Devereux RB, Kjeldsen SE, Nieminen MS, et al . Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens. 2002;20:405-12. [PMID: 11875307] CrossrefMedlineGoogle Scholar2. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83:356-62. [PMID: 1984895] CrossrefMedlineGoogle Scholar3. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Dahlöf B, et al . Reduction in urinary albumin/creatinine ratio during antihypertensive treatment translates to reduced risk for cardiovascular complications [Abstract]. The LIFE study. J Hypertens. 2003;21:S225. MedlineGoogle Scholar4. Ibsen H, Wachtell K, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in patients with hypertension and left ventricular hypertrophy? A LIFE substudy. J Hypertens. 2004 [In press]. Google Scholar Author, Article, and Disclosure InformationAffiliations: From Copenhagen, Denmark. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoAlbuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study Kristian Wachtell , Hans Ibsen , Michael H. Olsen , Knut Borch-Johnsen , Lars H. Lindholm , Carl Erik Mogensen , Bjrn Dahlf , Richard B. Devereux , Gareth Beevers , Ulf de Faire , Frej Fyhrquist , Stevo Julius , Sverre E. Kjeldsen , Krister Kristianson , Ole Lederballe-Pedersen , Markku S. Nieminen , Peter M. Okin , Per Omvik , Suzanne Oparil , Hans Wedel , Steven M. Snapinn , and Peter Aurup Albuminuria and Mortality in Hypertension Steven G. Coca and Gregory K. Buller Metrics Cited ByClinical Usefulness of a New Equation for Estimating Body Fat 3 August 2004Volume 141, Issue 3Page: 245KeywordsBlood pressureHazard ratioHypertensionMedical risk factorsMorbidityMortalitySystolic pressure ePublished: 3 August 2004 Issue Published: 3 August 2004 CopyrightCopyright © 2004 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...